牛牛AI助理已提取核心訊息
Robert Philibert, the Chief Medical Officer of Cardio Diagnostics Holdings, Inc. [CDIO], was involved in a transaction with the company's stock on January 23, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within the company.
Robert Philibert, the Chief Medical Officer of Cardio Diagnostics Holdings, Inc. [CDIO], was involved in a transaction with the company's stock on January 23, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within the company.
2024年1月23日,Cardio Diagnostics Holdings, Inc. [CDIO] 的首席醫學官羅伯特·菲利伯特參與了該公司股票的交易。該交易的具體細節,包括行動類型、狀態、股票數量、股票性質、交易價格和交易後持有量,未在公告中披露。這些信息對於投資者了解公司內部活動至關重要。
2024年1月23日,Cardio Diagnostics Holdings, Inc. [CDIO] 的首席醫學官羅伯特·菲利伯特參與了該公司股票的交易。該交易的具體細節,包括行動類型、狀態、股票數量、股票性質、交易價格和交易後持有量,未在公告中披露。這些信息對於投資者了解公司內部活動至關重要。
有用
沒用